Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole-ivermectin co-formulation versus albendazole for intestinal worms in children and adolescents
PACTR202011642671155Phase 3Recruiting
- Sponsor
- Barcelona Institute for Global Health
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised trial of albendazole and ivermectin in Soil-Transmitted Helminthiases (STH), trichuriasis, hookworm infection and 1 more (3 arms), sponsored by Barcelona Institute for Global Health. Primary endpoint: Cure rate for Trichuris trichiura. Started Aug 2021; status: recruiting.
02
Drugs
albendazoleivermectin
03
Conditions
Soil-Transmitted Helminthiases (STH)trichuriasishookworm infectionstrongyloidiasis
Beyond the preview
Go deeper on PACTR202011642671155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011642671155.